RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Poulikos I. Poulikakos(Memorial Sloan Kettering Cancer Center), Yogindra Persaud(Memorial Sloan Kettering Cancer Center), Manickam Janakiraman(Memorial Sloan Kettering Cancer Center), Xiangju Kong(University of California, Los Angeles), Charles Ng(University of California, Los Angeles), Gatien Moriceau(University of California, Los Angeles), Hubing Shi(University of California, Los Angeles), Mohammad Atefi(University of California, Los Angeles), Bjoern Titz(University of California, Los Angeles), May Tal Gabay(Memorial Sloan Kettering Cancer Center), Maayan Salton(National Cancer Institute), Kimberly B. Dahlman(Vanderbilt-Ingram Cancer Center), Madhavi Tadi(Memorial Sloan Kettering Cancer Center), Jennifer A. Wargo(Massachusetts General Hospital), Keith T. Flaherty(Massachusetts General Hospital), Mark C. Kelley(Vanderbilt University), Tom Misteli(National Cancer Institute), Paul B. Chapman(Memorial Sloan Kettering Cancer Center), Jeffrey A. Sosman(Vanderbilt University), Thomas G. Graeber(University of California, Los Angeles), Antoni Ribas(University of California, Los Angeles), Roger S. Lo(University of California, Los Angeles), Neal Rosen(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center)

Nature

November 22, 2011

Cited by 1,438

Abstract

No related papers found

Powered by citation graph analysis